ACRS · Aclaris Therapeutics, Inc. · Documents
$3.96
+0.17 (+4.49%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2024 earnings call transcript
Market Cap
$582.91M
Shares
147.20M
Volume · Oct 28
3.88M
Avg daily vol (3M)
2.89M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2021-11-02 | 2021-09-30 | |
| 8-K | — | 2021-11-02 | 2021-11-01 | |
| 8-K | — | 2021-08-27 | — | |
| 8-K | — | 2021-08-05 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-07-26 | 2021-07-23 | |
| 8-K | — | 2021-06-11 | 2021-06-08 | |
| 8-K | — | 2021-06-08 | — | |
| 8-K | — | 2021-06-03 | — | |
| S-3ASR | — | 2021-05-20 | — | |
| 8-K | — | 2021-05-20 | — | |
| 10-Q | — | 2021-05-07 | 2021-03-31 | |
| 8-K | — | 2021-05-07 | — | |
| DEF 14A | — | 2021-04-22 | 2021-06-03 | |
| DEFA14A | — | 2021-04-22 | — | |
| 8-K | — | 2021-02-25 | — | |
| 10-K | — | 2021-02-25 | 2020-12-31 | |
| 8-K | — | 2021-01-22 | 2021-01-19 | |
| 8-K | — | 2021-01-19 | — | |
| 8-K | — | 2020-12-15 | — | |
| 8-K | — | 2020-11-04 | — | |
| 10-Q | — | 2020-11-04 | 2020-09-30 | |
| 8-K | — | 2020-09-15 | — | |
| 8-K | — | 2020-08-14 | 2020-08-13 | |
| 8-K | — | 2020-08-13 | — | |
| 8-K | — | 2020-08-07 | — | |
| 10-Q | — | 2020-08-07 | 2020-06-30 | |
| 8-K | — | 2020-06-24 | 2020-06-23 | |
| 8-K | — | 2020-06-17 | — | |
| 8-K | — | 2020-06-04 | — | |
| 8-K | — | 2020-05-27 | — | |
| 8-K | — | 2020-05-15 | — | |
| 8-K | — | 2020-05-07 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| DEFA14A | — | 2020-04-23 | — | |
| DEF 14A | — | 2020-04-23 | 2020-06-04 | |
| 8-K | — | 2020-03-31 | 2020-03-30 | |
| 8-K | — | 2020-03-13 | — | |
| S-3 | — | 2020-03-13 | — | |
| 8-K | — | 2020-02-25 | — | |
| 10-K | — | 2020-02-25 | 2019-12-31 | |
| 8-K | — | 2020-01-13 | — | |
| 8-K | — | 2020-01-08 | 2020-01-07 |
Showing 101–143 of 143 filings
Key facts
CIK
1557746
CUSIP
00461U105
13F (30d)
27 filings
22 filers
Visit website
Investor relations